ES2062507T3 - Acido flavonacetico fluorado. - Google Patents

Acido flavonacetico fluorado.

Info

Publication number
ES2062507T3
ES2062507T3 ES90901973T ES90901973T ES2062507T3 ES 2062507 T3 ES2062507 T3 ES 2062507T3 ES 90901973 T ES90901973 T ES 90901973T ES 90901973 T ES90901973 T ES 90901973T ES 2062507 T3 ES2062507 T3 ES 2062507T3
Authority
ES
Spain
Prior art keywords
flavonacetic
fluorated
acid
fluorinated
acetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90901973T
Other languages
English (en)
Inventor
Paul A Aristoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ES2062507T3 publication Critical patent/ES2062507T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

UN ACIDO ACETICO DE FLAVONA FLUORINADO APTO PARA SER UTILIZADO COMO UN AGENTE ANTITUMORES. COMPUESTOS FARMACEUTICOS QUE CONTIENEN EL ACIDO ACETICO DE FLAVONA FLUORINADO Y UN PORTADOR FARMACEUTICAMENTE ACEPTABLE. UN COMPUESTO ANTITUMORES CONSTA DE UNA CANTIDAD EFICAZ ANTITUMORES DE UN ACIDO ACETICO DE FLAVONA FLUORINADO EN UN PORTADOR FARMACEUTICAMENTE ACEPTABLE.
ES90901973T 1989-01-19 1989-12-11 Acido flavonacetico fluorado. Expired - Lifetime ES2062507T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29910689A 1989-01-19 1989-01-19

Publications (1)

Publication Number Publication Date
ES2062507T3 true ES2062507T3 (es) 1994-12-16

Family

ID=23153335

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90901973T Expired - Lifetime ES2062507T3 (es) 1989-01-19 1989-12-11 Acido flavonacetico fluorado.

Country Status (9)

Country Link
EP (1) EP0454728B1 (es)
JP (1) JPH04502761A (es)
KR (1) KR910700240A (es)
AT (1) ATE102934T1 (es)
AU (1) AU4847390A (es)
CA (1) CA2006307A1 (es)
DE (1) DE68913997T2 (es)
ES (1) ES2062507T3 (es)
WO (1) WO1990008143A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH1427H (en) * 1988-04-06 1995-04-04 Briet; Phillipe Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
GB9707013D0 (en) * 1997-04-07 1997-05-28 Univ Strathclyde Halo and/or nitro-substituted flavonoids
KR102091852B1 (ko) * 2015-03-02 2020-03-23 코로나리콘셉츠 엘엘씨 Peg 대사산물 및 peg 분해 생성물 검정을 위한 화합물 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2516922A1 (fr) * 1981-11-25 1983-05-27 Lipha Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant

Also Published As

Publication number Publication date
JPH04502761A (ja) 1992-05-21
DE68913997D1 (de) 1994-04-21
KR910700240A (ko) 1991-03-14
ATE102934T1 (de) 1994-04-15
WO1990008143A1 (en) 1990-07-26
EP0454728A1 (en) 1991-11-06
DE68913997T2 (de) 1994-07-28
EP0454728B1 (en) 1994-03-16
CA2006307A1 (en) 1990-07-19
AU4847390A (en) 1990-08-13

Similar Documents

Publication Publication Date Title
BR9303469A (pt) Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas
GR3026218T3 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid
FI931031A (fi) Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
FI863652A0 (fi) 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
PT98105A (pt) Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
LV10953A (lv) Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija
MX9203320A (es) Composicion antialergica que contiene compuestos biciclicos switterionicos.
HUT64013A (en) Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DK0460062T3 (da) Huperzin A-analoger
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
IT1297205B1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
YU108691A (sh) Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
ES2062507T3 (es) Acido flavonacetico fluorado.
IT7850986A0 (it) 5-imminodaunomicina e suoi derivati procedimento per prepararla nonche'composizioni farmaceutiche che la contengono
GB2021409A (en) Pharmaceutical composition
MX9401172A (es) Derivados fluorados de 4-aminoandrostadienona, procesamiento para su preparacion y composiciones farmaceuticas que los contienen.
FI902901A0 (fi) Dibenzol/1,5/dioxocin-5-one-derivat, deras anvaendning i laekemedel och foerfarande foer deras framstaellning.
KR910700051A (ko) S-플루오로우라실계 화합물에 기인한 염증의 발생을 억제할 수 있는 비-주사제 형태의 항암 조성물 및 암의 치료방법
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
DE68908414D1 (de) Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes.
IT1218322B (it) Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
MX9203616A (es) Derivados de 4-amidino cromano y de 4-amidino[3,2-c] piridina y composiciones farmaceuticas que los contienen.
DE3473826D1 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 454728

Country of ref document: ES